{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T13:23:21Z","timestamp":1787664201035,"version":"build-2736575974"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Gastroenterol Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose of Review<\/jats:title>\n                    <jats:p>Surgery for inflammatory bowel disease (IBD) often results in alterations in gut function beyond the anatomical changes. While some patients develop short bowel syndrome (SBS), a significant proportion of IBD patients benefit from pharmacologic and dietary interventions for SBS even in the absence of true SBS or IF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent Findings<\/jats:title>\n                    <jats:p>While no formal criteria exist to clearly define the presence of SBS in IBD patients, the presence of specific features in the surgical and clinical history are crucial to the rapid identification of SBS or IF in IBD patients. Anatomy specific dietary considerations and interventions provide significant benefits and lay the foundation for a structured approach to optimizing anti-motility and adjunctive therapies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>IBD patients with post-surgical anatomy benefit from management strategies used in patients in SBS. Optimal dosing of anti-motility agents and oral rehydration solution form the foundations of management in all practice settings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11894-026-01054-1","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:59:23Z","timestamp":1787619563000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["One Patient, Two Problems: Applying Short Bowel Syndrome Management Principles in Inflammatory Bowel Disease patients"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4767-397X","authenticated-orcid":false,"given":"Adeeti J.","family":"Chiplunker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Burton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryn","family":"Koehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew L.","family":"Bechtold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"issue":"2","key":"1054_CR1","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.clnu.2017.04.013","volume":"37","author":"L Pironi","year":"2018","unstructured":"Pironi L, Konrad D, Brandt C, et al. Clinical classification of adult patients with chronic intestinal failure due to benign disease: An international multicenter cross-sectional survey. Clin Nutr. 2018;37(2):728\u201338. https:\/\/doi.org\/10.1016\/j.clnu.2017.04.013.","journal-title":"Clin Nutr"},{"issue":"2","key":"1054_CR2","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.clnu.2014.08.017","volume":"34","author":"L Pironi","year":"2015","unstructured":"Pironi L, Arends J, Baxter J, et al. ESPEN endorsed recommendations. Definition and classification of intestinal failure in adults. Clin Nutr. 2015;34(2):171\u201380. https:\/\/doi.org\/10.1016\/j.clnu.2014.08.017.","journal-title":"Clin Nutr"},{"issue":"Suppl 1","key":"1054_CR3","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1002\/ncp.10955","volume":"38","author":"L Pironi","year":"2023","unstructured":"Pironi L. Definition, classification, and causes of short bowel syndrome. Nutr Clin Pract. 2023;38(Suppl 1):S9\u201316. https:\/\/doi.org\/10.1002\/ncp.10955.","journal-title":"Nutr Clin Pract"},{"issue":"1 Suppl","key":"1054_CR4","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1177\/0148607113520005","volume":"38","author":"KA Tappenden","year":"2014","unstructured":"Tappenden KA. Pathophysiology of short bowel syndrome: considerations of resected and residual anatomy. JPEN J Parenter Enter Nutr. 2014;38(1 Suppl):S14\u201322. https:\/\/doi.org\/10.1177\/0148607113520005.","journal-title":"JPEN J Parenter Enter Nutr"},{"key":"1054_CR5","doi-asserted-by":"publisher","first-page":"3440","DOI":"10.3748\/wjg.v27.i24.3440","volume":"27","author":"A Aksan","year":"2021","unstructured":"Aksan A, Farrag K, Blumenstein I, et al. Chronic intestinal failure and short bowel syndrome in Crohn\u2019s disease. World J Gastroenterol. 2021;27:3440\u201365. https:\/\/doi.org\/10.3748\/wjg.v27.i24.3440.","journal-title":"World J Gastroenterol"},{"key":"1054_CR6","doi-asserted-by":"publisher","unstructured":"International Organization for the Study of IBD, Turner D, Ricciuto A, et al. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD. 160. 2021;1570\u201383. https:\/\/doi.org\/10.1053\/j.gastro.2020.12.031.","DOI":"10.1053\/j.gastro.2020.12.031"},{"key":"1054_CR7","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/ajg.2009.579","volume":"105","author":"L Peyrin-Biroulet","year":"2010","unstructured":"Peyrin-Biroulet L, Loftus EV Jr, Colombel J-F, et al. The natural history of adult Crohn\u2019s disease in population-based cohorts. Am J Gastroenterol. 2010;105:289\u201397. https:\/\/doi.org\/10.1038\/ajg.2009.579.","journal-title":"Am J Gastroenterol"},{"key":"1054_CR8","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1097\/DCR.0000000000001716","volume":"63","author":"AL Lightner","year":"2020","unstructured":"Lightner AL, Vogel JD, Carmichael JC, et al. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Surgical Management of Crohn\u2019s Disease. Dis Colon Rectum. 2020;63:1028\u201352. https:\/\/doi.org\/10.1097\/DCR.0000000000001716.","journal-title":"Dis Colon Rectum"},{"key":"1054_CR9","doi-asserted-by":"publisher","unstructured":"Tappenden KA. Intestinal adaptation following resection. JPEN J Parenter Enter Nutr. 2014;38:23S-31S https:\/\/doi.org\/10.1177\/0148607114525210.","DOI":"10.1177\/0148607114525210"},{"key":"1054_CR10","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1111\/j.1572-0241.2004.30345.x","volume":"99","author":"JK DiBaise","year":"2004","unstructured":"DiBaise JK, Young RJ, Vanderhoof JA. Intestinal Rehabilitation and the Short Bowel Syndrome: Part 1. Am J Gastroenterol. 2004;99:1386\u201395. https:\/\/doi.org\/10.1111\/j.1572-0241.2004.30345.x.","journal-title":"Am J Gastroenterol"},{"key":"1054_CR11","doi-asserted-by":"publisher","unstructured":"Schwartzberg DM, Brandstetter S, Grucela AL. Crohn\u2019s disease of the esophagus, duodenum, and stomach. Clin Colon Rectal Surg. 2019;32:231\u201342. https:\/\/doi.org\/10.1055\/s-0039-1683850.","DOI":"10.1055\/s-0039-1683850"},{"key":"1054_CR12","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1080\/15563650.2026.2634757","volume":"64","author":"E Bekka","year":"2026","unstructured":"Bekka E, Martinez-De la Torre A, Haschke M, et al. Toxicity profile of supratherapeutic loperamide: a systematic review and dose\u2013response analysis. Clin Toxicol (Phila). 2026;64:250\u201364. https:\/\/doi.org\/10.1080\/15563650.2026.2634757.","journal-title":"Clin Toxicol (Phila)"},{"key":"1054_CR13","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1097\/MOG.0000000000000985","volume":"40","author":"D Dahlgren","year":"2024","unstructured":"Dahlgren D, Hellstr\u00f6m PM. Medicinal grade opium tincture for severe diarrhea: effect revisited in observational study. Curr Opin Gastroenterol. 2024;40:196\u2013202. https:\/\/doi.org\/10.1097\/MOG.0000000000000985.","journal-title":"Curr Opin Gastroenterol"},{"key":"1054_CR14","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1038\/ajg.2009.329","volume":"104","author":"AN Atia","year":"2009","unstructured":"Atia AN, Buchman AL. Oral rehydration solutions in non-cholera diarrhea: a review. Am J Gastroenterol. 2009;104:2596\u2013604. https:\/\/doi.org\/10.1038\/ajg.2009.329. quiz 2605.","journal-title":"Am J Gastroenterol"},{"key":"1054_CR15","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1152\/physrev.00055.2009","volume":"91","author":"EM Wright","year":"2011","unstructured":"Wright EM, Loo DDF, Hirayama BA. Biology of Human Sodium Glucose Transporters. Physiol Rev. 2011;91:733\u201394. https:\/\/doi.org\/10.1152\/physrev.00055.2009.","journal-title":"Physiol Rev"},{"key":"1054_CR16","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/jpen.70050","volume":"50","author":"AJ Hoeg","year":"2026","unstructured":"Hoeg AJ, Jaques J, Johnson R, et al. Oral rehydration solution for the management of fluid and electrolyte disturbances in patients with an ileostomy: A scoping review. JPEN J Parenter Enter Nutr. 2026;50:339\u201351. https:\/\/doi.org\/10.1002\/jpen.70050.","journal-title":"JPEN J Parenter Enter Nutr"},{"key":"1054_CR17","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.amjsurg.2024.02.045","volume":"233","author":"SE Bradley","year":"2024","unstructured":"Bradley SE, Vitous CA, Marzoughi M, et al. Patient adherence to an oral rehydration solution intervention to prevent dehydration following ileostomy creation: A qualitative study. Am J Surg. 2024;233:120\u20134. https:\/\/doi.org\/10.1016\/j.amjsurg.2024.02.045.","journal-title":"Am J Surg"},{"key":"1054_CR18","doi-asserted-by":"publisher","unstructured":"Westfall KM, Rivard SJ, Suwanabol PA, et al. Postoperative oral rehydration and regimented follow-up decrease readmissions after colorectal surgery that includes ileostomies. Dis Colon Rectum. 2024;67. https:\/\/doi.org\/10.1097\/DCR.0000000000002935.","DOI":"10.1097\/DCR.0000000000002935"},{"key":"1054_CR19","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.3390\/nu11071485","volume":"11","author":"KJ Sollanek","year":"2019","unstructured":"Sollanek KJ, Kenefick RW, Cheuvront SN. Osmolality of Commercially Available Oral Rehydration Solutions: Impact of Brand, Storage Time, and Temperature. Nutrients. 2019;11:1485. https:\/\/doi.org\/10.3390\/nu11071485.","journal-title":"Nutrients"},{"key":"1054_CR20","unstructured":"Carol Rees Parrish MS R. Staying Hydrated with Oral Rehydration Solution. 2021. https:\/\/www.shortbowelsyndrome.com\/Content\/pdf\/Recipe_Book_DIGITAL.pdf. Accessed 16 April 2026."},{"key":"1054_CR21","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1177\/0115426505020005493","volume":"20","author":"LE Matarese","year":"2005","unstructured":"Matarese LE, O\u2019Keefe SJ, Kandil HM, et al. Short Bowel Syndrome: Clinical Guidelines for Nutrition Management. Nutr Clin Pract. 2005;20:493\u2013502. https:\/\/doi.org\/10.1177\/0115426505020005493.","journal-title":"Nutr Clin Pract"},{"key":"1054_CR22","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1111\/j.1572-0241.2004.40836.x","volume":"99","author":"JK DiBaise","year":"2004","unstructured":"DiBaise JK, Young RJ, Vanderhoof JA. Intestinal Rehabilitation and the Short Bowel Syndrome: Part 2. Am J Gastroenterol. 2004;99:1823\u201332. https:\/\/doi.org\/10.1111\/j.1572-0241.2004.40836.x.","journal-title":"Am J Gastroenterol"},{"key":"1054_CR23","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1016\/j.clnu.2023.07.019","volume":"42","author":"L Pironi","year":"2023","unstructured":"Pironi L, Cuerda C, Jeppesen PB, et al. ESPEN guideline on chronic intestinal failure in adults - Update 2023. Clin Nutr. 2023;42:1940\u20132021. https:\/\/doi.org\/10.1016\/j.clnu.2023.07.019.","journal-title":"Clin Nutr"},{"key":"1054_CR24","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1177\/0148607112469818","volume":"37","author":"LE Matarese","year":"2013","unstructured":"Matarese LE. Nutrition and Fluid Optimization for Patients With Short Bowel Syndrome. JPEN J Parenter Enter Nutr. 2013;37:161\u201370. https:\/\/doi.org\/10.1177\/0148607112469818.","journal-title":"JPEN J Parenter Enter Nutr"},{"key":"1054_CR25","doi-asserted-by":"publisher","first-page":"S101","DOI":"10.1177\/014860719902300525","volume":"23","author":"PB Jeppesen","year":"1999","unstructured":"Jeppesen PB, Mortensen PB. Colonic Digestion and Absorption of Energy From Carbohydrates and Medium-Chain Fat in Small Bowel Failure. JPEN J Parenter Enter Nutr. 1999;23:S101\u20135. https:\/\/doi.org\/10.1177\/014860719902300525.","journal-title":"JPEN J Parenter Enter Nutr"},{"key":"1054_CR26","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1080\/08998280.2020.1712926","volume":"33","author":"KM Rowe","year":"2020","unstructured":"Rowe KM, Schiller LR. Ileostomy diarrhea: Pathophysiology and management. Proc (Bayl Univ Med Cent). 2020;33:218\u201326. https:\/\/doi.org\/10.1080\/08998280.2020.1712926.","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"1054_CR27","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1111\/codi.12992","volume":"17","author":"E Clarebrough","year":"2015","unstructured":"Clarebrough E, Guest G, Stupart D. Eating marshmallows reduces ileostomy output: a randomized crossover trial. Colorectal Dis. 2015;17:1100\u20133. https:\/\/doi.org\/10.1111\/codi.12992.","journal-title":"Colorectal Dis"},{"key":"1054_CR28","doi-asserted-by":"publisher","unstructured":"Yusuf K, Saha S, Umar S. Health benefits of dietary fiber for the management of inflammatory bowel disease. Biomedicines. 2022;10. https:\/\/doi.org\/10.3390\/biomedicines10061242.","DOI":"10.3390\/biomedicines10061242"},{"key":"1054_CR29","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s11894-025-00975-7","volume":"27","author":"S Gold","year":"2025","unstructured":"Gold S, Park S, Katz J, et al. The Evolving Guidelines on Fiber Intake for Patients with Inflammatory Bowel Disease; From Exclusion to Texture Modification. Curr Gastroenterol Rep. 2025;27:23. https:\/\/doi.org\/10.1007\/s11894-025-00975-7.","journal-title":"Curr Gastroenterol Rep"},{"key":"1054_CR30","unstructured":"Crohn\u2019s and Colitis Foundation. Gut Friendly Recipes. 2026. https:\/\/www.crohnscolitisfoundation.org\/patientandcaregivers\/gutfriendlyrecipes. Accessed 19 April 2026."},{"key":"1054_CR31","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1093\/ibd\/izae037","volume":"31","author":"S Gold","year":"2025","unstructured":"Gold S, Levinson C, Colombel J-F, et al. Dietary Interventions and Supplementation in Patients With an Ileal Pouch\u2013Anal Anastomosis: A Systematic Review. Inflamm Bowel Dis. 2025;31:246\u201358. https:\/\/doi.org\/10.1093\/ibd\/izae037.","journal-title":"Inflamm Bowel Dis"},{"key":"1054_CR32","doi-asserted-by":"publisher","first-page":"332","DOI":"10.5009\/gnl14397","volume":"9","author":"M Camilleri","year":"2015","unstructured":"Camilleri M. Bile Acid Diarrhea: Prevalence, Pathogenesis, and Therapy. Gut Liver. 2015;9:332\u20139. https:\/\/doi.org\/10.5009\/gnl14397.","journal-title":"Gut Liver"},{"key":"1054_CR33","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/0016-5085(85)90197-0","volume":"89","author":"LR Schiller","year":"1985","unstructured":"Schiller LR, Santa Ana CA, Morawski SG, et al. Studies of the antidiarrheal action of clonidine. Effects on motility and intestinal absorption. Gastroenterology. 1985;89:982\u20138. https:\/\/doi.org\/10.1016\/0016-5085(85)90197-0.","journal-title":"Gastroenterology"},{"key":"1054_CR34","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1177\/0148607106030006487","volume":"30","author":"AL Buchman","year":"2006","unstructured":"Buchman AL, Fryer J, Wallin A, et al. Clonidine reduces diarrhea and sodium loss in patients with proximal jejunostomy: a controlled study. JPEN J Parenter Enter Nutr. 2006;30:487\u201391. https:\/\/doi.org\/10.1177\/0148607106030006487.","journal-title":"JPEN J Parenter Enter Nutr"},{"key":"1054_CR35","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1177\/0148607104028004265","volume":"28","author":"K McDoniel","year":"2004","unstructured":"McDoniel K, Taylor B, Huey W, et al. Use of clonidine to decrease intestinal fluid losses in patients with high-output short-bowel syndrome. JPEN J Parenter Enter Nutr. 2004;28:265\u20138. https:\/\/doi.org\/10.1177\/0148607104028004265.","journal-title":"JPEN J Parenter Enter Nutr"},{"key":"1054_CR36","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/s0885-3924(99)00149-9","volume":"19","author":"S Kornblau","year":"2000","unstructured":"Kornblau S, Benson AB, Catalano R, et al. Management of cancer treatment-related diarrhea. Issues and therapeutic strategies. J Pain Symptom Manage. 2000;19:118\u201329. https:\/\/doi.org\/10.1016\/s0885-3924(99)00149-9.","journal-title":"J Pain Symptom Manage"},{"key":"1054_CR37","doi-asserted-by":"publisher","first-page":"584175","DOI":"10.2147\/DMSO.S584175","volume":"19","author":"N Y\u0131lmaz","year":"2026","unstructured":"Y\u0131lmaz N, Bastemir M. Gastrointestinal Adverse Effects of GLP-1 and Dual GLP-1\/GIP Receptor Agonists: A Comprehensive Update in Diabetic and Obese Populations. Diabetes Metab Syndr Obes. 2026;19:584175. https:\/\/doi.org\/10.2147\/DMSO.S584175.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"1054_CR38","doi-asserted-by":"publisher","unstructured":"Gorard L, Boucher M, Rutter C. Glucagon-like peptide agonists and use in short bowel syndrome \u2013 what about the side effects? Curr Opin Gastroenterol. 2026;42. https:\/\/doi.org\/10.1097\/MOG.0000000000001169.","DOI":"10.1097\/MOG.0000000000001169"},{"key":"1054_CR39","doi-asserted-by":"publisher","first-page":"1610368","DOI":"10.3389\/fimmu.2025.1610368","volume":"16","author":"G Migliorisi","year":"2025","unstructured":"Migliorisi G, Gabbiadini R, Dal Buono A, et al. GLP-1 receptor agonists in IBD: exploring the crossroads of metabolism and inflammation. Front Immunol. 2025;16:1610368. https:\/\/doi.org\/10.3389\/fimmu.2025.1610368.","journal-title":"Front Immunol"},{"key":"1054_CR40","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jcmgh.2016.05.001","volume":"2","author":"BW Warner","year":"2016","unstructured":"Warner BW. The Pathogenesis of Resection-Associated Intestinal Adaptation. Cell Mol Gastroenterol Hepatol. 2016;2:429\u201338. https:\/\/doi.org\/10.1016\/j.jcmgh.2016.05.001.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"1054_CR41","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1053\/gast.2001.22555","volume":"120","author":"PB Jeppesen","year":"2001","unstructured":"Jeppesen PB, Hartmann B, Thulesen J, et al. Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon. Gastroenterology. 2001;120:806\u201315. https:\/\/doi.org\/10.1053\/gast.2001.22555.","journal-title":"Gastroenterology"},{"key":"1054_CR42","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1053\/j.gastro.2012.09.007","volume":"143","author":"PB Jeppesen","year":"2012","unstructured":"Jeppesen PB, Pertkiewicz M, Messing B, et al. Teduglutide Reduces Need for Parenteral Support Among Patients With Short Bowel Syndrome With Intestinal Failure. Gastroenterology. 2012;143:1473\u2013e14813. https:\/\/doi.org\/10.1053\/j.gastro.2012.09.007.","journal-title":"Gastroenterology"},{"key":"1054_CR43","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.cgh.2012.12.029","volume":"11","author":"SJD O\u2019Keefe","year":"2013","unstructured":"O\u2019Keefe SJD, Jeppesen PB, Gilroy R, et al. Safety and Efficacy of Teduglutide After 52 Weeks of Treatment in Patients With Short Bowel Intestinal Failure. Clin Gastroenterol Hepatol. 2013;11:815\u2013e8233. https:\/\/doi.org\/10.1016\/j.cgh.2012.12.029.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1054_CR44","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1002\/ncp.11139","volume":"39","author":"D Micic","year":"2024","unstructured":"Micic D, Robinson I, Kidd T, et al. Teduglutide improves liver chemistries in short bowel syndrome\u2013associated intestinal failure: Post hoc analysis. Nutr Clin Pract. 2024;39:634\u201340. https:\/\/doi.org\/10.1002\/ncp.11139.","journal-title":"Nutr Clin Pract"},{"key":"1054_CR45","doi-asserted-by":"publisher","unstructured":"Pironi L, Allard JP, Joly F et al. Use of teduglutide in adults with short bowel syndrome\u2013associated intestinal failure 2024;39:141\u201353. https:\/\/doi.org\/10.1002\/ncp.11015","DOI":"10.1002\/ncp.11015"},{"key":"1054_CR46","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1097\/mcg.0000000000000604","volume":"51","author":"B Kochar","year":"2017","unstructured":"Kochar B, Long MD, Shelton E, et al. Safety and Efficacy of Teduglutide (Gattex) in Patients With Crohn\u2019s Disease and Need for Parenteral Support Due to Short Bowel Syndrome\u2013associated Intestinal Failure. J Clin Gastroenterol. 2017;51:508. https:\/\/doi.org\/10.1097\/mcg.0000000000000604.","journal-title":"J Clin Gastroenterol"},{"key":"1054_CR47","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1093\/ibd\/zaa010.053","volume":"26","author":"A Chiplunker","year":"2020","unstructured":"Chiplunker A, Ha C, Paski S, P108 TEDUGLUTIDE USE IN CROHN\u2019S DISEASE: A CASE SERIES. Inflamm Bowel Dis. 2020;26:S23. https:\/\/doi.org\/10.1093\/ibd\/zaa010.053.","journal-title":"Inflamm Bowel Dis"}],"container-title":["Current Gastroenterology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-026-01054-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11894-026-01054-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-026-01054-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T13:02:46Z","timestamp":1787662966000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11894-026-01054-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1054"],"URL":"https:\/\/doi.org\/10.1007\/s11894-026-01054-1","relation":{},"ISSN":["1534-312X"],"issn-type":[{"value":"1534-312X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"assertion":[{"value":"7 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"AJC reports research contracts with Abbvie, Eli Lilly, Ironwood, Takeda, and Janssen Biotech, advisory board work with Ironwood Pharmaceuticals, and educational funding support from the Nestle Nutrition Institute.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"27"}}